GLP-1 drugs NOT associated with increased risk of thyroid cancer in large medical record database November 16, 2023 Sometimes, when a drug is used in a huge number of people, we discover an adverse effect that wasnt evident during clinical studies
2 GLP-1 RAs, such as semaglutide, also show potential anti-inflammatory properties
These drugs mimic the action of the naturally occurring hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating blood sugar levels
Restoring Insulin Sensitivity at the Cellular Level Insulin resistance is largely driven by chronic inflammation, poor muscle mass, nutrient deficiencies, and blood sugar volatility
Body Protection Compound-157 (BPC-157) earned the "healing peptide" label through its broad, multi-system reparative activity observed across preclinical models, covering muscle, tendon, ligament, bone, and gastrointestinal tissue repair